secwatch.observer — SEC 8-K summary
======================================

Issuer:     BioRestorative Therapies, Inc. (BRTX)
CIK:        0001505497
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0001493152-23-012377
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BioRestorative enters ATM equity facility with JonesTrading for up to $3.7M
---------------------------------------------------------------------------

- Capital On Demand Sales Agreement signed April 14, 2023 with JonesTrading Institutional Services LLC.
- Company may sell up to $3.7 million of common stock from time to time in at-the-market offerings.
- Agent commission is 3.0% of gross sale proceeds; company not obligated to sell any shares.
- Sales will be under existing effective S-3 registration statement (No. 333-269631) filed Feb 2023.
- Agreement can be terminated by either party at any time upon notice.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1505497/000149315223012377/0001493152-23-012377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1505497/000149315223012377/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-012377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer